ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety ...

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval ...

Is the impact of the war in the Middle East on Irish consumers becoming any clearer? The situation is still best described as ...

Pakistan is implementing major measures to ensure fuel stability amid trade slowdown due to the Strait of Hormuz closure.

Oil markets are being shaken once again globally by geopolitical strains in the Middle East. The mounting tension between the ...

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a ...

US FDA approves Novartis Cosentyx for paediatric patients aged 12+ with moderate to severe hidradenitis suppurativa: Basel Monday, March 16, 2026, 14:00 Hrs [IST] Novartis announc ...

Johnson & Johnson (JNJ) on Wednesday announced that the U.S. Food and Drug Administration (FDA) approved Icotyde, a once-daily pill developed with Protagonist Therapeutics (PTGX), as a treatment for ...

Heating oil has shot up in price, petrol and diesel may continue to climb, but it may take longer to see the effect on ...

College Place Middle School hosted its first Multicultural Night on Thursday, Feb. 26, drawing more than 130 students, ...

Find all the best things to do in Pittsburgh this weekend, from NatureFest to the Pittsburgh Fringe Festival to the Japanese ...